Arbutus Biopharma (ABUS) Shares Issued (2013 - 2026)

Arbutus Biopharma has disclosed Shares Issued across 14 years of filings, most recently posting $11.5 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $11.5 million, up 8702.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (down 61.13% YoY), and the FY2025 annual result was $181000.0, down 97.58% from the prior year.
• Shares Issued came in at $11.5 million for Q1 2026 at Arbutus Biopharma, up from -$3.7 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $22.4 million in Q2 2024 to a low of -$3.7 million in Q4 2025.
• The 5-year median for Shares Issued is $547000.0 (2022), against an average of $3.6 million.
• Across the five-year window, Shares Issued surged 708000.0% in 2024 and plunged 152.52% in 2025, its largest moves.
• Arbutus Biopharma's Shares Issued stood at $9.0 million in 2022, then tumbled by 99.99% to $1000.0 in 2023, then soared by 708000.0% to $7.1 million in 2024, then tumbled by 152.52% to -$3.7 million in 2025, then surged by 410.06% to $11.5 million in 2026.
• The last three Shares Issued figures came in at $11.5 million (Q1 2026), -$3.7 million (Q4 2025), and $794000.0 (Q3 2025), per Business Quant data.